Trial Profile

Multi-Center, Randomized, Double-Blind, Phase III Trial to Assess the Immunogenicity and Safety of Primary Vaccination With NBP606 in Healthy Infants

Status: Completed

Phase of Trial: Phase III

Latest Information Update: 21 Apr 2020

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs NBP 606 (Primary) ; Pneumococcal vaccine
Indications Pneumococcal infections
Focus Registrational; Therapeutic Use
Sponsors SK Chemicals

Most Recent Events

17 Apr 2020 Status changed from recruiting to completed.
21 Jun 2016 Planned primary completion date changed from 1 Jul 2015 to 1 Jun 2016.
21 Jun 2016 Planned End Date changed from 1 Jul 2015 to 1 Dec 2016.

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com